SC
GILD icon

Stolper & Co’s Gilead Sciences GILD Stock Holding History

Stolper & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,496
Closed -$1.04M – 89
2020
Q3 		$1.04M Sell
16,496
-64
-0.4% -$4.44K 0.67% 49
2020
Q2 		$1.27M Sell
16,560
-530
-3% -$40.6K 0.83% 43
2020
Q1 		$1.28M Buy
+17,090
New +$1.18M 0.92% 41

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stolper & Co's GILD Position: Q4 2020 in Review

Stolper & Co sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 16,496 shares — an estimated $1.04M sold.

Stolper & Co first reported a position in GILD in Q1 2020 and held it in 3 quarters. The position peaked at $1.28M in Q1 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Stolper & Co reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Stolper & Co sold 16,496 Gilead Sciences shares in Q4 2020, an estimated $1.04M.
  • Stolper & Co first reported a position in Gilead Sciences in Q1 2020 and held it in 3 quarters.
  • Stolper & Co's Gilead Sciences position peaked at $1.28M in Q1 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Stolper & Co's 13F filing for Q4 2020, filed 11 Jan 2021.